Home » RELIANT PHARMACEUTICALS PULLS IPO DUE TO CONDITIONS
RELIANT PHARMACEUTICALS PULLS IPO DUE TO CONDITIONS
Reliant Pharmaceuticals Inc., which markets branded cardiovascular pharmaceutical products, on Thursday withdrew its planned $300 million initial public offering due to unfavorable market conditions. Since filing a preliminary offering document with the U.S. Securities and Exchange Commission in May, the company had not revealed the amount of shares or the estimated price range.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May